Results
|
|
10101.
|
|
|
|
10102.
|
|
|
|
10103.
|
|
|
|
10104.
|
|
|
|
10105.
|
|
|
|
10106.
|
|
|
|
10107.
|
|
|
|
10108.
|
|
|
|
10109.
|
|
|
|
10110.
|
|
|
|
10111.
|
|
|
|
10112.
|
|
|
|
10113.
|
|
|
|
10114.
|
|
|
|
10115.
|
|
|
|
10116.
|
Intensive chemotherapy with idarubicin, ara-C, etoposide, and m-AMSA followed by immunotherapy with interleukin-2 for myelodysplastic syndromes and high-risk Acute Myeloid Leukemia (AML). [electronic resource] by
- Ganser, A
- Heil, G
- Seipelt, G
- Hofmann, W
- Fischer, J T
- Langer, W
- Brockhaus, W
- Kolbe, K
- Ittel, T H
- Brack, N
- Fuhr, H G
- Knuth, P
- Höffken, K
- Bergmann, L
- Hoelzer, D
Producer: 20000229
In:
Annals of hematology vol. 79
Availability: No items available.
|
|
|
10117.
|
|
|
|
10118.
|
Dexa-BEAM: an effective regimen for cytoreduction prior to high-dose chemotherapy with autologous stem cell support for patients with relapsed/refractory mantle-cell lymphoma. [electronic resource] by
- Josting, A
- Reiser, M
- Wickramanayake, P D
- Rueffer, U
- Draube, A
- Söhngen, D
- Tesch, H
- Wolf, J
- Diehl, V
- Engert, A
Producer: 20000518
In:
Leukemia & lymphoma vol. 37
Availability: No items available.
|
|
|
10119.
|
Combination chemotherapy with risk factor-adjusted dose attenuation for high-risk myelodysplastic syndrome and resulting leukemia in the multicenter study of the Japan Adult Leukemia Study Group (JALSG): results of an interim analysis. [electronic resource] by
- Okamoto, T
- Kanamaru, A
- Shimazaki, C
- Motoji, T
- Takemoto, Y
- Takahashi, M
- Fukushima, T
- Takeshita, A
- Kusumoto, G S
- Kishimoto, Y
- Yorimitsu, S
- Tsukuda, K
- Uike, N
- Arima, N
- Ohno, R
Producer: 20001205
In:
International journal of hematology vol. 72
Availability: No items available.
|
|
|
10120.
|
|